Latham NH, et al. - The researcher investigated the acceptability of point of care hepatitis C tests among people who inject drugs (PWID) in this nested qualitative study. They used the OraQuick HCV antibody mouth swab (result in 20 minutes) to screen PWID attending participating needle substitution programmes; venepuncture was then performed on those with a reactive result for a point of care RNA test: the Xpert HCV Viral Load (result in 105 minutes). They interviewed 19 participants, most of whom reported that even if a finger stick point of care RNA test were an option in the future, they would prefer venepuncture, as the sample could be used for pre-treatment workup and bundled testing. This study thus suggests the acceptability of offering point of care hepatitis C testing at needle substitution programmes to PWID, however, the tests that avoid venepuncture are not necessarily the most attractive to PWID.